Jubilant Pharmova Ltd

Desk›Healthcare› Jubilant Pharmova Ltd

BSE 530019 · NSE JUBLPHARMA · ISIN INE700A01033 · Group A · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹878.85

-1.00%

BSE close, 28 August 2026

Market cap

₹13,998.42 cr

15.9 cr shares · Small cap

Free float

₹7,064.08 cr

as published

P/E · P/B

216.5× · 6.09×

EPS ₹4.06 · BV ₹144.31

FY25-26 rev / PAT

263.50 / 63.20

₹ cr, as filed

Filings, window

3 selected · 14%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

Against 52-week high	-25.8%
Against 52-week low	+12.1%
Day change	-1.00%
Size band	Small cap
Index membership	NIFTY 500

Valuation as published by BSE

Earnings per share	₹4.06
Price / earnings	216.47×
Price / book	6.09×
Book value — derived, price ÷ P/B	₹144.31
Return on equity	2.81%
Operating margin	18.03%
Net margin	10.88%

Consistency check

P/B ÷ P/E, which must equal ROE: 2.81%
ROE as published: 2.81%

Results ₹ crore, as filed

Jun-26 · Q

Mar-26 · Q

FY25-26

RevenueNet profit one scale across all three periods, ₹ crore

Period	Revenue ₹cr	Net profit ₹cr	EPS ₹	OPM	NPM
Jun-26 · Q	67.10	7.30	0.46	18.03%	10.88%
Mar-26 · Q	70.30	57.20	3.59	8.96%	81.37%
FY25-26	263.50	63.20	1.25	16.13%	23.98%

Quarter on quarter

Revenue, quarter on quarter: -4.6%
Net profit, quarter on quarter: -87.2%
Operating margin, quarter on quarter: +907 bps

Disclosure profile 22 filings in the window

Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.

Tag	Filings
Selected
Board Outcome	1
Press Release	1
Results	1
Selected sub-total	3
Procedural
General	8
Board Meeting	3
AGM / EGM	2
Postal Ballot	2
Analyst / Investor Meet	1
Compliance Certificate	1
Newspaper Publication	1
Trading Window	1
Procedural sub-total	19
Total	22

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

22 filings · 3 selected · busiest 2026-08-10

Filing rhythm · the twelve most recent

2026-08-172026-10-08

SelectedProcedural

Filings

22 in the window · 11 earlier on record

8 October 2026 · 21:23 IST

General

Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Intimation under regulation 30

Company Update / General View filing →
7 October 2026 · 19:43 IST

Board Meeting

Board Meeting Intimation for To Consider And Approve Raising Of Funds Through The Issuance Of Non-Convertible Debentures (Ncds) And/Or Such Other Securities As May Be Permitted Under Applicable Laws, And To Approve Seeking Shareholders' Approval, As May Be Required

Jubilant Pharmova Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/10/2026 ,inter alia, to consider and approve To consider and approve raising ....

Board Meeting / Board Meeting View filing →
5 October 2026 · 18:53 IST

Compliance Certificate

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Compliance Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 for the Quarter ended September 30, 2026

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
29 September 2026 · 17:10 IST

Trading Window

Closure of Trading Window

Intimation regarding Closure of Trading Window for the Quarter ended September 30, 2026

Insider Trading / SAST / Closure of Trading Window View filing →
28 September 2026 · 18:46 IST

General

Specimen Letter Sent To Shareholders For Withheld Of Dividend For FY 2025-26

Specimen letter sent to shareholders for withheld of dividend for FY 2025-26

Company Update / General View filing →
11 September 2026 · 19:42 IST

General

Update On USFDA Spokane

Update on USFDA Spokane

Company Update / General View filing →
1 September 2026 · 12:42 IST

General

Receipt Of Show Cause Notice By Jubilant Pharmova Limited - GST

Receipt of Show Cause Notice by Jubilant Pharmova Limited - GST

Company Update / General View filing →
28 August 2026 · 10:08 IST

General

Receipt Of Show Cause Notice - Jubilant Generics Limited

Receipt of Show Cause Notice - Jubilant Generics Limited

Company Update / General View filing →
26 August 2026 · 20:07 IST

AGM / EGM

Shareholder Meeting / Postal Ballot-Scrutinizer's Report

Scrutinizer's Report

AGM/EGM / AGM View filing →
26 August 2026 · 20:05 IST

AGM / EGM

Shareholder Meeting / Postal Ballot-Outcome of AGM

Outcome of AGM

AGM/EGM / AGM View filing →
17 August 2026 · 19:49 IST

Postal Ballot

Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

Outcome of Postal Ballot

AGM/EGM / Postal Ballot View filing →
17 August 2026 · 19:44 IST

Postal Ballot

Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

Scrutinizer's Report

AGM/EGM / Postal Ballot View filing →
11 August 2026 · 18:23 IST

Newspaper Publication

Newspaper Publication

Newspaper Publications

Company Update / Newspaper Publication View filing →
10 August 2026 · 19:22 IST

Press Release

Press Release / Media Release

Press Release and presentation

Company Update / Press Release / Media Release View filing →
10 August 2026 · 19:17 IST

Results

Un-Audited Standalone & Consolidated Financial Results For The Quarter Ended June 30, 2026

Un-audited Financial Results for the Quarter ended June 30, 2026

Result / Financial Results View filing →
10 August 2026 · 19:14 IST

Board Outcome

Board Meeting Outcome for Meeting Held On August 10, 2026

outcome of Board meeting

Board Meeting / Outcome of Board Meeting View filing →
5 August 2026 · 16:57 IST

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Investors/ Analysts Meeting

Company Update / Analyst / Investor Meet View filing →
5 August 2026 · 16:41 IST

Board Meeting

Board Meeting Intimation for Postponement And Rescheduling Of Board Meeting Scheduled For August 10, 2026

Jubilant Pharmova Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve the Un-audited Standalone ....

Company Update / Board Meeting Rescheduled View filing →
30 July 2026 · 18:52 IST

General

Submission Of Copies Of Newspaper Advertisement Relating To Notice To Shareholders - Transfer Of Equity Shares/Dividend To IEPF

Submission of Copies of Newspaper Advertisement relating to Notice to Shareholders - Transfer of equity shares/dividend to IEPF

Company Update / General View filing →
30 July 2026 · 17:45 IST

Board Meeting

Board Meeting Intimation for Intimation Of Board Meeting Scheduled For August 07, 2026

Jubilant Pharmova Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve Intimation of Board Meeting ....

Board Meeting / Board Meeting View filing →
29 July 2026 · 19:53 IST

General

Communication Sent To Shareholders Relating To Notice Of Transfer To IEPF

Announcement under Regulation 30 (LODR) - Communication sent to shareholders relating to notice of transfer to IEPF

Company Update / General View filing →
29 July 2026 · 16:28 IST

General

Submission Of Copies Of Newspaper Publications - Annual General Meeting Of Jubilant Pharmova Limited Scheduled To Be Held On Wednesday, August 26, 2026 Through Video Conferencing/Other Audio Visual Means.

Submission of copies of Newspaper Publications - Annual General Meeting of Jubilant Pharmova Limited scheduled to be held on Wednesday, August 26, 2026 through Video Conferencing/Other ....

Company Update / General View filing →

RSS feed for Jubilant Pharmova Ltd · the 50 most recent filings

Price
Market cap
Sector
Index
PE
Latest quarter revenue
Net profit
Filings in the window